Rankings
▼
Calendar
XOMAP Q2 2025 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$13M
+18.4% YoY
Gross Profit
$12M
95.0% margin
Operating Income
$5M
35.1% margin
Net Income
$9M
70.0% margin
EPS (Diluted)
$0.52
QoQ Revenue Growth
-17.5%
Cash Flow
Operating Cash Flow
$6M
Free Cash Flow
$6M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$223M
Total Liabilities
$131M
Stockholders' Equity
$92M
Cash & Equivalents
$75M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$13M
$11M
+18.4%
Gross Profit
$12M
$10M
+25.7%
Operating Income
$5M
-$10M
+145.7%
Net Income
$9M
$16M
-42.5%
Geographic Segments
UNITED STATES
$7M
43%
SWITZERLAND
$6M
34%
Asia Pacific
$4M
23%
← Q1 2025
All Quarters
Q3 2025 →